World's first jab to stop skin cancer being tested in UK patients
- A personalized mRNA cancer jab is being tested in British patients for melanoma, with potential to target bladder, lung, and kidney cancer.
- In a trial, the jab reduced the risk of cancer recurrence in melanoma patients, leading to a final trial launch.
- The therapy involves DNA sequencing of a tumor sample and artificial intelligence, showing promising results for high-risk melanoma patients.
Insights by Ground AI
Does this summary seem wrong?
20 Articles
20 Articles
All
Left
5
Center
2
Right
4
Coverage Details
Total News Sources20
Leaning Left5Leaning Right4Center2Last UpdatedBias Distribution45% Left
Bias Distribution
- 45% of the sources lean Left
45% Left
L 45%
C 18%
R 36%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage